These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17484146)

  • 1. Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.
    Stein D; Bindra DS
    Pharm Dev Technol; 2007; 12(1):71-7. PubMed ID: 17484146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro dissolution of theophylline from different types of hard shell capsules.
    Podczeck F; Jones BE
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
    Wu Y; Zhao F; Paborji M
    Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The shell dissolution of various empty hard capsules.
    Chiwele I; Jones BE; Podczeck F
    Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):951-6. PubMed ID: 10923822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPMC capsules: current status and future prospects.
    Al-Tabakha MM
    J Pharm Pharm Sci; 2010; 13(3):428-42. PubMed ID: 21092714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid Based Formulations in Hard Gelatin and HPMC Capsules: a Physical Compatibility Study.
    Koehl NJ; Shah S; Tenekam ID; Khamiakova T; Sauwen N; Vingerhoets S; Coppenolle H; Holm R
    Pharm Res; 2021 Aug; 38(8):1439-1454. PubMed ID: 34378150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gelatin and Non-Gelatin Capsule Dosage Forms.
    Gullapalli RP; Mazzitelli CL
    J Pharm Sci; 2017 Jun; 106(6):1453-1465. PubMed ID: 28209365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
    Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
    Kuentz M; Rothenhäusler B; Röthlisberger D
    Drug Dev Ind Pharm; 2006; 32(10):1165-73. PubMed ID: 17090439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy.
    El-Malah Y; Nazzal S; Bottom CB
    Drug Dev Ind Pharm; 2007 Jan; 33(1):27-34. PubMed ID: 17192248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semisolid matrix filled capsules: an approach to improve dissolution stability of phenytoin sodium formulation.
    El Massik MA; Abdallah OY; Galal S; Daabis NA
    Drug Dev Ind Pharm; 2003 May; 29(5):531-43. PubMed ID: 12779283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and comparison of physicomechanical characteristics of gelatin and hypromellose capsules.
    Missaghi S; Fassihi R
    Drug Dev Ind Pharm; 2006 Aug; 32(7):829-38. PubMed ID: 16908420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
    Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules.
    Curatolo W; Liu P; Johnson BA; Hausberger A; Quan E; Vendola T; Vatsaraj N; Foulds G; Vincent J; Chandra R
    Pharm Res; 2011 Jul; 28(7):1531-9. PubMed ID: 21331473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
    Cole ET; Scott RA; Cade D; Connor AL; Wilding IR
    Pharm Res; 2004 May; 21(5):793-8. PubMed ID: 15180336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity.
    Ciper M; Bodmeier R
    Eur J Pharm Biopharm; 2006 Feb; 62(2):178-84. PubMed ID: 16260126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glycine/citric acid on the dissolution stability of hard gelatin capsules.
    Adesunloye TA; Stach PE
    Drug Dev Ind Pharm; 1998 Jun; 24(6):493-500. PubMed ID: 9876614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the Dissolution Stability of Hard Gelatin Capsules Using Activated Carbon as a Packaging Component.
    Likar MD; Carroll SC; Colgan ST; Yeoh T; MacDonald BC; Johnson GM; Space JS
    J Pharm Sci; 2018 Dec; 107(12):3080-3088. PubMed ID: 30145210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D Printing and Dissolution Testing of Novel Capsule Shells for Use in Delivering Acetaminophen.
    Gaurkhede SG; Osipitan OO; Dromgoole G; Spencer SA; Pasqua AJD; Deng J
    J Pharm Sci; 2021 Dec; 110(12):3829-3837. PubMed ID: 34469748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.